Literature DB >> 10704241

Cell fractionation analysis of human CD8 glycoprotein transport between endoplasmic reticulum, intermediate compartment and Golgi complex in tissue cultured cells.

M C Erra1, L Iodice, L V Lotti, S Bonatti.   

Abstract

We have set up an analytical cell fractionation procedure to dissect, by a non-morphological method, the anterograde transport of proteins from endoplasmic reticulum, intermediate compartment and Golgi complex in tissue cultured cells. Using this procedure after pulse-chase labelling of cells expressing human CD8 glycoprotein, we obtained results that: (1) support the view that the intermediate compartment is a distinct station in the export from the endoplasmic reticulum to the Golgi complex; and (2) strongly suggests that the O -glycosylation process starts after the intermediate compartment, presumably in the cis -Golgi complex. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10704241     DOI: 10.1006/cbir.1999.0420

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  3 in total

1.  KDEL and KKXX retrieval signals appended to the same reporter protein determine different trafficking between endoplasmic reticulum, intermediate compartment, and Golgi complex.

Authors:  Mariano Stornaiuolo; Lavinia V Lotti; Nica Borgese; Maria-Rosaria Torrisi; Giovanna Mottola; Gianluca Martire; Stefano Bonatti
Journal:  Mol Biol Cell       Date:  2003-03       Impact factor: 4.138

2.  PrP(C) association with lipid rafts in the early secretory pathway stabilizes its cellular conformation.

Authors:  Daniela Sarnataro; Vincenza Campana; Simona Paladino; Mariano Stornaiuolo; Lucio Nitsch; Chiara Zurzolo
Journal:  Mol Biol Cell       Date:  2004-06-30       Impact factor: 4.138

3.  NKG2D ligand MICA is retained in the cis-Golgi apparatus by human cytomegalovirus protein UL142.

Authors:  Omodele Ashiru; Neil J Bennett; Louise H Boyle; Mair Thomas; John Trowsdale; Mark R Wills
Journal:  J Virol       Date:  2009-09-30       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.